Search

Your search keyword '"Yusof, Nik Yusnoraini"' showing total 24 results
Start Over Author "Yusof, Nik Yusnoraini"
24 results on '"Yusof, Nik Yusnoraini"'

6. Current and Future Technologies for the Detection of Antibiotic-Resistant Bacteria

Author

Yamin, Dina, primary, Uskoković, Vuk, additional, Wakil, Abubakar Muhammad, additional, Goni, Mohammed Dauda, additional, Shamsuddin, Shazana Hilda, additional, Mustafa, Fatin Hamimi, additional, Alfouzan, Wadha A., additional, Alissa, Mohammed, additional, Alshengeti, Amer, additional, Almaghrabi, Rana H., additional, Fares, Mona A. Al, additional, Garout, Mohammed, additional, Al Kaabi, Nawal A., additional, Alshehri, Ahmad A., additional, Ali, Hamza M., additional, Rabaan, Ali A., additional, Aldubisi, Fatimah Abdullah, additional, Yean, Chan Yean, additional, and Yusof, Nik Yusnoraini, additional

Published
2023
Full Text
View/download PDF

7. Immunoinformatic Execution and Design of an Anti-Epstein–Barr Virus Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses

Author

Ahmed, Naveed, primary, Rabaan, Ali A., additional, Alwashmi, Ameen S. S., additional, Albayat, Hawra, additional, Mashraqi, Mutaib M., additional, Alshehri, Ahmad A., additional, Garout, Mohammed, additional, Abduljabbar, Wesam A., additional, Yusof, Nik Yusnoraini, additional, and Yean, Chan Yean, additional

Published
2023
Full Text
View/download PDF

8. Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV

Author

Ahmed, Naveed, primary, Abusalah, Mai Abdel Haleem A., additional, Farzand, Anam, additional, Absar, Muhammad, additional, Yusof, Nik Yusnoraini, additional, Rabaan, Ali A., additional, AlSaihati, Hajir, additional, Alshengeti, Amer, additional, Alwarthan, Sara, additional, Alsuwailem, Haifa S., additional, Alrumaih, Zainb A., additional, Alsayyah, Ahmed, additional, and Yean, Chan Yean, additional

Published
2022
Full Text
View/download PDF

13. Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.

Author

Ahmed, Naveed, Abusalah, Mai Abdel Haleem A., Farzand, Anam, Absar, Muhammad, Yusof, Nik Yusnoraini, Rabaan, Ali A., AlSaihati, Hajir, Alshengeti, Amer, Alwarthan, Sara, Alsuwailem, Haifa S., Alrumaih, Zainb A., Alsayyah, Ahmed, and Yean, Chan Yean

Subjects
NASOPHARYNX cancer, EPSTEIN-Barr virus, EPITHELIAL cell tumors, B cell lymphoma, SMOOTH muscle tumors, IMMUNOLOGIC memory
Abstract

Nasopharyngeal carcinoma (NPC) is an uncommon type of malignancy/cancer worldwide. However, NPC is an endemic disease in southeast Asia and southern China and the reasons behind the underlying for such changes are unclear. Even though the Epstein–Barr infection (EBV) has been suggested as an important reason for undistinguishable NPC, the EBV itself is not adequate to source this type of cancer. The risk factors, for example, genetic susceptibility, and environmental factors might be associated with EBV to undertake a part in the NPC carcinogenesis. Normal healthy people have a memory B cell pool where the EBV persists, and any disturbance of this connection leads to virus-associated B cell malignancies. Less is known about the relationship between EBV and epithelial cell tumors, especially the EBV-associated nasopharyngeal carcinoma (EBVaNPC) and EBV-associated gastric carcinoma (EBVaGC). Currently, it is believed that premalignant genetic changes in epithelial cells contribute to the aberrant establishment of viral latency in these tumors. The early and late phases of NPC patients' survival rates vary significantly. The presence of EBV in all tumor cells presents prospects for the development of innovative therapeutic and diagnostic techniques, despite the fact that the virus's exact involvement in the carcinogenic process is presently not very well known. EBV research continues to shed light on the carcinogenic process, which is important for a more comprehensive knowledge of tumor etiology and the development of targeted cancer therapeutics. In order to screen for NPC, EBV-related biomarkers have been widely used in a few high-incidence locations because of their close associations with the risks of NPC. The current review highlights the scientific importance of EBV and its possible association with NPC. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

15. Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis

Author

Mohd Asri, Nur Ain, primary, Ahmad, Suhana, additional, Mohamud, Rohimah, additional, Mohd Hanafi, Nurmardhiah, additional, Mohd Zaidi, Nur Fatihah, additional, Irekeola, Ahmad Adebayo, additional, Shueb, Rafidah Hanim, additional, Yee, Leow Chiuan, additional, Mohd Noor, Norhayati, additional, Mustafa, Fatin Hamimi, additional, Yean, Chan Yean, additional, and Yusof, Nik Yusnoraini, additional

Published
2021
Full Text
View/download PDF

17. A Global Mutational Profile of SARS-CoV-2: A Systematic Review and Meta-Analysis of 368,316 COVID-19 Patients

Author

Yusof, Wardah, primary, Irekeola, Ahmad Adebayo, additional, Wada, Yusuf, additional, Engku Abd Rahman, Engku Nur Syafirah, additional, Ahmed, Naveed, additional, Musa, Nurfadhlina, additional, Khalid, Muhammad Fazli, additional, Rahman, Zaidah Abdul, additional, Hassan, Rosline, additional, Yusof, Nik Yusnoraini, additional, and Yean Yean, Chan, additional

Published
2021
Full Text
View/download PDF

20. In Silico Analysis and 3D Structure Prediction of Putative UDP-Glycosyltransferase 76G1 Protein in Stevia rebaudiana MS007.

Author

Mokthar, Nor Iswani, Samsulrizal, Muhammad Amirul Husni, Khan, Afiqah Ramatullah, Zainuddin, Zarina, Sundram, Tamil Chelvan Meenakshi, Yusof, Nik Yusnoraini, and Samsulrizal, Nurul Hidayah

Subjects
STEVIA rebaudiana, TERTIARY structure, MOLECULAR phylogeny, NATURAL sweeteners, COMMON sunflower
Abstract

Stevia rebaudiana is a plant of the Asteraceae family that is used as a natural sweetener. Stevia has been shown to be safe for human consumption and has been utilised as a sweetener substitute for diabetic and obese people. In this study, the structure and gene content involved in the synthesis of putative UDP-glycosyltransferase 76G1 (UGT76G1) protein in S. rebaudiana MS007 were analysed using an in-silico method. Homologous search using BlastP revealed the highest percentage of identity, score, and E-value for UDP-glycosyltransferase 76G1-like of Helianthus annuus (ID: XP_021973845.1). The presence of IPR002213 UDP-glucuronosyl/UDP-glucosyltransferase entry, which is available at locations 89bp to 246 bp, was also verified by the protein family search using InterPro. MEGA-X software was used to construct a molecular phylogeny study, revealing that this protein belongs to the Asteraceae family. To predict the primary, secondary, and tertiary protein structures of the putative UGT76G1 protein, the ProtParam, ExPasy, PSIPRED, and Phyre2 programmes were implemented. The putative UGT76G1 protein's tertiary structure prediction was given a score of 100.0% confidence by the single highest scoring template and a coverage of 98%, with the dimension of the model being (Å) of X: 52.453, Y: 61.270, and Z: 48.102. The UGT76G1 model fulfilled the quality standards and was approved for further analysis after validation performed by PROCHECK, VERIFY3D, and ERRAT. Thus, the findings of this work have contributed to a better knowledge of putative UDP-glycosyltransferase 76G1 features and target recognition processes, which will lead to better information on protein-protein interaction in S. rebaudiana MS007. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results